Home ›
Entities
› academia
› Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening
Research article (GeroScience, 2025) · cited 10× · AI/ML
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening
Summary
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening is a scholarly article[1].
Key Facts
Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening. Retrieved May 24, 2026, from https://4ort.xyz/entity/aging-mitochondrial-dysfunction-and-cerebral-microhemorrhages-a-preclinical-evaluation-of-ss-31-elamipretide-and-develop
MLA“Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/aging-mitochondrial-dysfunction-and-cerebral-microhemorrhages-a-preclinical-evaluation-of-ss-31-elamipretide-and-develop.
BibTeX@misc{4ortxyz_aging-mitochondrial-dysfunction-and-cerebral-microhemorrhages-a-preclinical-evaluation-of-ss-31-elamipretide-and-develop_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening}}, year = {2026}, url = {https://4ort.xyz/entity/aging-mitochondrial-dysfunction-and-cerebral-microhemorrhages-a-preclinical-evaluation-of-ss-31-elamipretide-and-develop}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Aging, mitochondrial dysfunction, and cerebral microhemorrhages: a preclinical evaluation of SS-31 (elamipretide) and development of a high-throughput machine learning-driven imaging pipeline for cerebromicrovascular protection therapeutic screening — https://4ort.xyz/entity/aging-mitochondrial-dysfunction-and-cerebral-microhemorrhages-a-preclinical-evaluation-of-ss-31-elamipretide-and-develop (retrieved 2026-05-24)